Re: Schulz, The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 2006;208:187-198

Comment

. 2007 Feb;211(3):379-80.

doi: 10.1002/path.2093.

Comment

C Costa et al. J Pathol. 2007 Feb.

. 2007 Feb;211(3):379-80.

doi: 10.1002/path.2093.

No abstract available

Comment on

The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF. Schulz TF. J Pathol. 2006 Jan;208(2):187-98. doi: 10.1002/path.1904. J Pathol. 2006. PMID: 16362980 Review.

[Human herpesvirus 8 (HHV8). II. Pathogenic role and sensitivity to antiviral drugs].
Boulanger E. Boulanger E. Ann Biol Clin (Paris). 1999 Jan-Feb;57(1):19-28. Ann Biol Clin (Paris). 1999. PMID: 9920963 Review. French.
[Herpesvirus 8, Kaposi sarcoma and other lymphoproliferative diseases].
Benfield T. Benfield T. Ugeskr Laeger. 2002 Dec 9;164(50):5932-3. Ugeskr Laeger. 2002. PMID: 12553113 Danish. No abstract available.
Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T, Sato Y, Nakamura T, Sakamoto K, Sata T, Katano H. Kanno T, et al. J Med Virol. 2010 Mar;82(3):400-6. doi: 10.1002/jmv.21715. J Med Virol. 2010. PMID: 20087946
Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A, Schulz TF. Viejo-Borbolla A, et al. AIDS Rev. 2003 Oct-Dec;5(4):222-9. AIDS Rev. 2003. PMID: 15012001 Review.
Conjugal HHV-8 infection with cutaneous Kaposi's sarcomas and Castleman's disease: fortuitous association or not?
Granel B, Serratrice J, Zandotti C, Rey J, De Roux C, Horschowski N, Disdier P, Weiller PJ. Granel B, et al. Dermatology. 2000;200(2):153-4. doi: 10.1159/000018353. Dermatology. 2000. PMID: 10773709 No abstract available.